PTIE Pain Therapeutics gains 69% Jan 25, 2018

Pain Therapeutics, Inc., a biopharmaceutical company, develops drugs for treating nervous system in the United States. The company's lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimer's disease and other neurological disorders. The company was founded in 1998 and is based in Austin, Texas. http://www.priceseries.com/trade/PTIE-Pain-Therapeutics-stock-gains-69-percent-a-Trade-Record-by-priceSeries-2018010820180125.html